• Rabeprazole (20mg) +Domperidone (30mg) thumbnail 1
  • Rabeprazole (20mg) +Domperidone (30mg) thumbnail 3
  • Rabeprazole (20mg) +Domperidone (30mg) thumbnail 4
  • Rabeprazole (20mg) +Domperidone (30mg) thumbnail 5
Rabeprazole (20mg) +Domperidone (30mg)
Product Brochure

Rabeprazole (20mg) +Domperidone (30mg)

₹ 110/Box

CompositionRabeprazole 20mg and Domperidone 30mg, Rabeprazole 20mg and Domperidone 30mg
Pack Size10*10 Capsules
Packaging TypeBox
Brand NameRABGST DSR
Strength50 mg
ManufacturerUnited medox
Shelf Life36 Months
Usages/ApplicationTo neutralize excessive acid in the stomach
Prescription/Non-PrescriptionPrescription
Also GivesPCD Pharma Franchise
Country of OriginMade in India
AvailabilityIn Stock
DOMPERIDONE+RABEPRAZOLE is used to treat symptoms of acid reflux due to hyperacidity, stomach ulcer (Peptic ulcer disease), and Zollinger-Ellison syndrome (overproduction of acid due to a pancreatic tumour). Besides this, it is used short-term to treat gastroesophageal reflux disease (GERD) symptoms.

Find products similar to Rabeprazole (20mg) +Domperidone (30mg)

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromBavla
ShippingAs per delivery location

Product Image

Rabeprazole (20mg) +Domperidone (30mg) image 1Rabeprazole (20mg) +Domperidone (30mg) image 2Rabeprazole (20mg) +Domperidone (30mg) image 3Rabeprazole (20mg) +Domperidone (30mg) image 4

About the Company

GST Registration Date
Dec 2024
Legal Status of Firm
Partnership
Nature of Business
NA
Number of Employees
11 To 25 People
IndiaMART Member Since
Nov 2017
GST
24**********1ZJ

United Medox is the industry-leading are Wholesaler And Retailer firm commenced its business operations in the year 2024 to bring forth best quality Pharmaceutical Cough Syrup, Pharmaceutical Capsules, Pharmaceutical Tablets, Pharmaceutical Gel and many more. Our offered range of high-quality products is manufactured by utilizing carefully selected inventory of raw materials to render beneficial attributes of robust quality construction and competitive price ban.